2003-2004年和2011-2012年国家健康调查(NHANES)中不饱和脂肪酸循环水平与糖尿病前期风险之间的关系。

IF 6.1 3区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Liwen Zhang , Jiayi Liu , Yuxuan Cao , Shan Liu , Weili Zhao , Ci Wang , Shangfang Banzhao , Zanchao Liu , Lipeng Liu
{"title":"2003-2004年和2011-2012年国家健康调查(NHANES)中不饱和脂肪酸循环水平与糖尿病前期风险之间的关系。","authors":"Liwen Zhang ,&nbsp;Jiayi Liu ,&nbsp;Yuxuan Cao ,&nbsp;Shan Liu ,&nbsp;Weili Zhao ,&nbsp;Ci Wang ,&nbsp;Shangfang Banzhao ,&nbsp;Zanchao Liu ,&nbsp;Lipeng Liu","doi":"10.1016/j.diabres.2024.111728","DOIUrl":null,"url":null,"abstract":"<div><h3>Aims</h3><p>This study aimed to investigate the association between serum levels of common and uncommon unsaturated fatty acids and prediabetes risk.</p></div><div><h3>Methods</h3><p>Data were collected from the National Health and Nutrition Examination Survey for 2003–2004 and 2011–2012. Weighted proportional and multivariate logistic regression analyses were performed to assess the association of serum PUFAs and MUFAs with prediabetes risk after adjusting for potential confounders.</p></div><div><h3>Results</h3><p>A total of 3575 individuals were enrolled in this study. Serum levels of PUFAs EPA (20:5 n3) and GLA (18:3 n6) were associated with increased prediabetes risk (EPA (20:5 n3): OR = 1.878, 95% CI: 1.177–2.996, <em>P<sub>trend</sub></em> = 0.002; GLA (18:3 n6): 1.702, 95% CI: 1.140–2.541, <em>P<sub>trend</sub></em> = 0.016). The MUFAs PA (16:1 n7) and EA (20:1 n9) were associated with the risk of prediabetes (OR in quintile5: PA (16:1 n7): 1.780, 95% CI: 1.056–3.001, <em>P<sub>trend</sub></em> = 0.003; EA (20:1 n9): 0.587, 95% CI: 0.347–0.994, <em>P<sub>trend</sub></em> = 0.010). Moreover, nonlinear analysis revealed that serum levels of EPA (20:5 n3) and EA (20:1 n-9) were nonlinearly associated with prediabetes risk.</p></div><div><h3>Conclusion</h3><p>Some serum n-3 PUFAs are positively associated with prediabetes, several serum n-6 PUFAs are inversely associated with prediabetes. Regulating individual serum USFA levels may help prevent prediabetes, thereby providing evidence for clinical and nutritional practices.</p></div>","PeriodicalId":11249,"journal":{"name":"Diabetes research and clinical practice","volume":null,"pages":null},"PeriodicalIF":6.1000,"publicationDate":"2024-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0168822724006387/pdfft?md5=973a3a1f0578f8e7a1e5f97f10dda18c&pid=1-s2.0-S0168822724006387-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Association between circulating levels of unsaturated fatty acids and risk for prediabetes in the NHANES 2003–2004 and 2011–2012\",\"authors\":\"Liwen Zhang ,&nbsp;Jiayi Liu ,&nbsp;Yuxuan Cao ,&nbsp;Shan Liu ,&nbsp;Weili Zhao ,&nbsp;Ci Wang ,&nbsp;Shangfang Banzhao ,&nbsp;Zanchao Liu ,&nbsp;Lipeng Liu\",\"doi\":\"10.1016/j.diabres.2024.111728\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Aims</h3><p>This study aimed to investigate the association between serum levels of common and uncommon unsaturated fatty acids and prediabetes risk.</p></div><div><h3>Methods</h3><p>Data were collected from the National Health and Nutrition Examination Survey for 2003–2004 and 2011–2012. Weighted proportional and multivariate logistic regression analyses were performed to assess the association of serum PUFAs and MUFAs with prediabetes risk after adjusting for potential confounders.</p></div><div><h3>Results</h3><p>A total of 3575 individuals were enrolled in this study. Serum levels of PUFAs EPA (20:5 n3) and GLA (18:3 n6) were associated with increased prediabetes risk (EPA (20:5 n3): OR = 1.878, 95% CI: 1.177–2.996, <em>P<sub>trend</sub></em> = 0.002; GLA (18:3 n6): 1.702, 95% CI: 1.140–2.541, <em>P<sub>trend</sub></em> = 0.016). The MUFAs PA (16:1 n7) and EA (20:1 n9) were associated with the risk of prediabetes (OR in quintile5: PA (16:1 n7): 1.780, 95% CI: 1.056–3.001, <em>P<sub>trend</sub></em> = 0.003; EA (20:1 n9): 0.587, 95% CI: 0.347–0.994, <em>P<sub>trend</sub></em> = 0.010). Moreover, nonlinear analysis revealed that serum levels of EPA (20:5 n3) and EA (20:1 n-9) were nonlinearly associated with prediabetes risk.</p></div><div><h3>Conclusion</h3><p>Some serum n-3 PUFAs are positively associated with prediabetes, several serum n-6 PUFAs are inversely associated with prediabetes. Regulating individual serum USFA levels may help prevent prediabetes, thereby providing evidence for clinical and nutritional practices.</p></div>\",\"PeriodicalId\":11249,\"journal\":{\"name\":\"Diabetes research and clinical practice\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":6.1000,\"publicationDate\":\"2024-06-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S0168822724006387/pdfft?md5=973a3a1f0578f8e7a1e5f97f10dda18c&pid=1-s2.0-S0168822724006387-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes research and clinical practice\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0168822724006387\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes research and clinical practice","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0168822724006387","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

目的:本研究旨在探讨血清中常见和不常见不饱和脂肪酸水平与糖尿病前期风险之间的关系:数据收集自2003-2004年和2011-2012年全国健康与营养调查。在调整了潜在的混杂因素后,进行了加权比例和多变量逻辑回归分析,以评估血清中的 PUFA 和 MUFA 与糖尿病前期风险的关系:共有 3575 人参与了这项研究。血清中的 PUFAs EPA(20:5 n3)和 GLA(18:3 n6)水平与糖尿病前期风险的增加有关(EPA (20:5 n3):OR = 1.878, 95% CI: 1.177-2.996, Ptrend = 0.002; GLA (18:3 n6):1.702,95% CI:1.140-2.541,Ptrend = 0.016)。MUFAs PA(16:1 n7)和 EA(20:1 n9)增加了糖尿病前期的风险(OR 在五分位数 5:PA(16:1 n7):1.780,95% CI:1.140-2.541,Ptren = 0.016):1.780, 95% CI: 1.056-3.001, Ptrend = 0.003; EA (20:1 n9):0.587,95% CI:0.347-0.994,Ptrend = 0.010)。此外,非线性分析表明,血清中 EPA(20:5 n3)和 EA(20:1 n-9)的水平与糖尿病前期风险呈非线性关系:结论:一些血清中的 n-3 PUFA 与糖尿病前期呈正相关,一些血清中的 n-6 PUFA 与糖尿病前期呈反相关。调节个人血清中的 USFA 水平有助于预防糖尿病前期,从而为临床和营养实践提供证据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Association between circulating levels of unsaturated fatty acids and risk for prediabetes in the NHANES 2003–2004 and 2011–2012

Aims

This study aimed to investigate the association between serum levels of common and uncommon unsaturated fatty acids and prediabetes risk.

Methods

Data were collected from the National Health and Nutrition Examination Survey for 2003–2004 and 2011–2012. Weighted proportional and multivariate logistic regression analyses were performed to assess the association of serum PUFAs and MUFAs with prediabetes risk after adjusting for potential confounders.

Results

A total of 3575 individuals were enrolled in this study. Serum levels of PUFAs EPA (20:5 n3) and GLA (18:3 n6) were associated with increased prediabetes risk (EPA (20:5 n3): OR = 1.878, 95% CI: 1.177–2.996, Ptrend = 0.002; GLA (18:3 n6): 1.702, 95% CI: 1.140–2.541, Ptrend = 0.016). The MUFAs PA (16:1 n7) and EA (20:1 n9) were associated with the risk of prediabetes (OR in quintile5: PA (16:1 n7): 1.780, 95% CI: 1.056–3.001, Ptrend = 0.003; EA (20:1 n9): 0.587, 95% CI: 0.347–0.994, Ptrend = 0.010). Moreover, nonlinear analysis revealed that serum levels of EPA (20:5 n3) and EA (20:1 n-9) were nonlinearly associated with prediabetes risk.

Conclusion

Some serum n-3 PUFAs are positively associated with prediabetes, several serum n-6 PUFAs are inversely associated with prediabetes. Regulating individual serum USFA levels may help prevent prediabetes, thereby providing evidence for clinical and nutritional practices.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Diabetes research and clinical practice
Diabetes research and clinical practice 医学-内分泌学与代谢
CiteScore
10.30
自引率
3.90%
发文量
862
审稿时长
32 days
期刊介绍: Diabetes Research and Clinical Practice is an international journal for health-care providers and clinically oriented researchers that publishes high-quality original research articles and expert reviews in diabetes and related areas. The role of the journal is to provide a venue for dissemination of knowledge and discussion of topics related to diabetes clinical research and patient care. Topics of focus include translational science, genetics, immunology, nutrition, psychosocial research, epidemiology, prevention, socio-economic research, complications, new treatments, technologies and therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信